Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Apr 28, 2015 (11 years ago)

Kabiven

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Labeling: Label Error on Declared Strength: Labeled 3.1% Amino Acids but contains 3.3% Amino Acids

Cause type: Labeling / mix-up

Wrong label, wrong strength, mixed-up products, or packaging errors. One of the most dangerous causes - you can end up taking the wrong drug or the wrong dose. All labeling / mix-up recalls.

What was recalled

KABIVEN [(3.9%) Lipid Injectable Emulsion with (3.1%) Amino Acids and Electrolytes and (9.8%) Dextrose; Sulfite-free], Rx Only. Manufactured by: FRESENIUS KABI Uppsala, Sweden. Packaged in 1) 1,540 mL Bags, NDC: 63323-712-15, and 2) 2,053 mL Bags, NDC: 63323-712-20.

Affected NDCs 63323-0712-15 63323-0712-20

Compare with the code on your package — it is the most precise check available.

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
Kabiven
Dextrose, Soybean oil, Electrolytes, Lysine, Phenylalanine, Leucine, Valine, Threonine, Methionine, Isoleucine, Tryptophan, Alanine, Arginine, Glycine, Proline, Histidine, Glutamic Acid, Serine, Aspartic Acid and Tyrosine
NDC 63323-0712
DEXTROSE MONOHYDRATE 10.8 g/100mL; SOYBEAN OIL 3.9 g/100mL; SODIUM ACETATE 239 mg/100mL; POTASSIUM CHLORIDE 174 mg/100mL; SODIUM GLYCEROPHOSPHATE ANHYDROUS 147 mg/100mL; MAGNESIUM SULFATE HEPTAHYDRATE 96 mg/100mL; CALCIUM CHLORIDE 29 mg/100mL; LYSINE HYDROCHLORIDE 263 mg/100mL; PHENYLALANINE 231 mg/100mL; LEUCINE 231 mg/100mL; VALINE 213 mg/100mL; HISTIDINE 199 mg/100mL; THREONINE 164 mg/100mL; METHIONINE 164 mg/100mL; ISOLEUCINE 164 mg/100mL; TRYPTOPHAN 55 mg/100mL; ALANINE 467 mg/100mL; ARGININE 330 mg/100mL; GLYCINE 231 mg/100mL; PROLINE 199 mg/100mL; GLUTAMIC ACID 164 mg/100mL; SERINE 131 mg/100mL; ASPARTIC ACID 99 mg/100mL; TYROSINE 6.7 mg/100mL Injection, Emulsion
Intravenous
Fresenius Kabi USA, LLC Rx
Recalling firm
Fresenius Kabi USA, LLC
Origin
IL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1114-2015 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other recalls by Fresenius Kabi USA, LLC

All 2015 recalls
Class I · High risk

Tyenne (tocilizumab-aazg)

Presence of particulate matter:An internal investigation at the firm found the product to contain glass particles.

Ongoing Particulate / foreign matter Fresenius Kabi USA, LLC NDC 65219-594-20 D-0827-2026
Class I · High risk

Morphine Sulfate Injection

Labeling: Label Mixup: MicroVault labeled as Morphine 2 mg/1 mL, contains a Prefilled Syringe of Dilaudid 0.5 mg/0.5 mL.

Ongoing Labeling / mix-up Fresenius Kabi USA, LLC D-0788-2026

Other labeling / mix-up recalls from 2015

All labeling / mix-up recalls
Class III · Low risk

NABUMETONE Tablets USP

Labeling: Not Elsewhere Classified: Lack of leaflets and approved labels on bottles.

Terminated Labeling / mix-up Teva Pharmaceuticals USA D-0773-2016
Class II · Moderate risk

Rocuronium Bromide 50 MG/5ML INJ.

Labeling: Incorrect Instructions; RemedyRepack, Inc. a relabeler, is recalling these products due to incorrect storage instructions.

Terminated Labeling / mix-up RemedyRepack Inc. NDC 61786-0222-57 D-0517-2016